1060P HER2-XPAT, a novel protease-activatable pro-drug T-cell engager (TCE), engineered to address on-target, off tumour toxicity and provide large predicted safety margins in non-human primate (NHP)
| Autor: | Cattaruzza, F., Nazeer, A., Lange, Z., Koski, C., Hammond, M., Henkensiefken, A., Hostetter, D., Derynck, M., Schellenberger, V., Irving, B. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S723-S723 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|